Probiotic therapy of intestinal inflammation and infections.
about
Divergent pro-inflammatory profile of human dendritic cells in response to commensal and pathogenic bacteria associated with the airway microbiotaProinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis.Lactobacillus acidophilus ameliorates H. pylori-induced gastric inflammation by inactivating the Smad7 and NFκB pathwaysDeciphering the porcine intestinal microRNA transcriptome.3-D intestinal scaffolds for evaluating the therapeutic potential of probioticsAn anti-HIV microbicide comes aliveProbiotics and prebiotics in chronic inflammatory bowel diseases.Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'.Helping patients make informed choices about probiotics: a need for research.Extracellular vesicles modulate host-microbe responses by altering TLR2 activity and phagocytosis.Determination of the discriminant score of intestinal microbiota as a biomarker of disease activity in patients with ulcerative colitisThe immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept)Lactobacillus protects the integrity of intestinal epithelial barrier damaged by pathogenic bacteriaThe anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition.Successful treatment of asymptomatic or clinically terminal bovine Mycobacterium avium subspecies paratuberculosis infection (Johne's disease) with the bacterium Dietzia used as a probiotic alone or in combination with dexamethasone: Adaption to chrCommensal and Pathogenic Escherichia coli Metabolism in the Gut.Differential targeting of the E-Cadherin/β-Catenin complex by gram-positive probiotic lactobacilli improves epithelial barrier functionIdentification of commensal bacterial strains that modulate Yersinia enterocolitica and dextran sodium sulfate-induced inflammatory responses: implications for the development of probiotics.Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colonThe struggle within: microbial influences on colorectal cancer.Analysis of the duodenal microbiotas of weaned piglet fed with epidermal growth factor-expressed Saccharomyces cerevisiaeL-fucose stimulates utilization of D-ribose by Escherichia coli MG1655 DeltafucAO and E. coli Nissle 1917 DeltafucAO mutants in the mouse intestine and in M9 minimal medium.Robustness trade-offs and host-microbial symbiosis in the immune systemTherapeutic approaches targeting intestinal microflora in inflammatory bowel disease.Current understanding of fungal microflora in inflammatory bowel disease pathogenesisThe angiogenic effect of probiotic Bacillus polyfermenticus on human intestinal microvascular endothelial cells is mediated by IL-8.The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel disease.A multistrain probiotic formulation attenuates skin symptoms of atopic dermatitis in a mouse model through the generation of CD4+Foxp3+ T cells.A Potential 'Curative' Modality for Crohn's Disease---Modeled after Prophylaxis of Bovine Johne's Disease.Precolonized human commensal Escherichia coli strains serve as a barrier to E. coli O157:H7 growth in the streptomycin-treated mouse intestine.The Role of Probiotics in IBD.Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress.Lactobacillus crispatus M206119 exacerbates murine DSS-colitis by interfering with inflammatory responsesTherapeutic benefit of pentostatin in severe IL-10-/- colitis.Probiotic pretreatment improves survival and prevents gut mucosal barrier dysfunction in sepsis.Toll-like receptor 2 and nucleotide-binding oligomerization domain-2 play divergent roles in the recognition of gut-derived lactobacilli and bifidobacteria in dendritic cells.Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteria.
P2860
Q28731877-C2D11BEF-3ED7-4DB5-82E5-478514F232C6Q29619978-F1D30DDA-A003-48F3-8740-BA04FE998E70Q31051844-AE48B238-EB5F-478A-BBD6-7978AFE09CA2Q33569209-C6FC11D3-7590-47E7-BF73-593357633858Q33894653-AA23B817-D6DE-4F58-AFD6-7B2C8C007E26Q33934017-FA749274-F380-4624-9AD4-C9298AC265A9Q34013030-42CFAC28-EAF3-4401-B6BF-CFD3DBFE2979Q34588415-12569C72-73F1-4C0B-805C-72CFDCF1773DQ34973954-77464617-58F8-476B-A7B6-59163C60486AQ35106699-17A72259-76D0-41D9-A242-F3D90696D288Q35123540-01331566-1AC0-44CE-B5D0-B8CA88DA85B5Q35132150-0E07ECBC-422F-4039-8E82-C9A26C5D6ED5Q35216207-774961C4-7AFA-47CB-BEB2-C548DC778A01Q35571641-242D33E3-16C2-4C5A-A508-4A58284793E8Q35693684-BFB16AF0-A961-46C2-9187-D52B86CC0AB2Q35694190-DE1C5980-2169-4913-9439-7A425F059B91Q35739226-327153F5-D7BD-49A8-8B1D-A7920B1C743BQ35913648-D3611A78-1D5A-46A5-BDAD-3A94875B9ACFQ36000703-66F63332-2CBA-4390-9E76-568F9A83EBBAQ36036277-83BB8077-B909-436C-86AE-ABD62E584182Q36087601-5639D383-BC85-4DEB-A9DB-D190551CF768Q36313802-C85816BD-D8F8-480A-97B6-21804333C565Q36494119-61B8099D-F444-4C42-8F65-A77FD95D8DF6Q36549836-BF206A07-62AC-49EE-91BD-0AA384028D60Q37089171-217F84D4-F6BD-4511-8C1A-8609EED27D4EQ37421164-AA4AA438-8AA8-47CC-BED3-604BEAF45202Q38044907-F7AF3013-1F3A-4E42-B4F5-8166D02F96A1Q41643868-43BC5634-C81D-4617-BE44-16474AD7299EQ41905099-009FCE66-7507-4279-884C-9B179505FAACQ42033739-0ABB01AD-BF0F-4635-BA07-BE3FE6AD51C1Q42038763-E8A8297F-A62A-4CEE-B736-A7C222CC04B6Q42078864-B1B1BB59-7A31-4F3A-AECF-80828DA11227Q42172347-11451564-E9A2-48CA-8120-860D1D139068Q42705209-A025479E-BD4F-4D43-80E6-3E55909D0C1AQ46083506-9135E0CA-15E2-4FAC-912C-BB6BCC8E57B5Q47961731-2E154B66-48AE-4061-91DF-27CF6B81112FQ54441343-7A8A1F7D-FEB4-4123-9521-38EB6E390F11
P2860
Probiotic therapy of intestinal inflammation and infections.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Probiotic therapy of intestinal inflammation and infections.
@ast
Probiotic therapy of intestinal inflammation and infections.
@en
Probiotic therapy of intestinal inflammation and infections.
@nl
type
label
Probiotic therapy of intestinal inflammation and infections.
@ast
Probiotic therapy of intestinal inflammation and infections.
@en
Probiotic therapy of intestinal inflammation and infections.
@nl
prefLabel
Probiotic therapy of intestinal inflammation and infections.
@ast
Probiotic therapy of intestinal inflammation and infections.
@en
Probiotic therapy of intestinal inflammation and infections.
@nl
P1476
Probiotic therapy of intestinal inflammation and infections
@en
P2093
R Balfour Sartor
P577
2005-01-01T00:00:00Z